Vaccination against H5 avian influenza virus induces long-term humoral immune responses in flamingoes (Phoenicopterus spp.)

被引:2
|
作者
Fernandez-Bellon, Hugo [1 ,2 ]
Vergara-Alert, Julia [3 ]
Almagro, Vanessa [1 ,2 ]
Rivas, Raquel [3 ]
Sanchez, Azucena [4 ]
Carmen Martinez, Maria [4 ]
Majo, Natalia [2 ,3 ]
Busquets, Nuria [3 ]
Ramis, Antonio [2 ,3 ]
机构
[1] Parc Zool Barcelona, Parc Ciutadella S-N, Barcelona 08003, Spain
[2] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain
[3] CReSA, IRTA, Campus Univ Autonoma Barcelona, Barcelona 08193, Spain
[4] Lab Cent Vet, Serv Virol, Ctra Algete,Km 8, Madrid 28110, Spain
关键词
Avian influenza; Zoo birds; Flamingo; Vaccination; Long-term immunity; H5N1; ZOO-BIRDS; HONG-KONG;
D O I
10.1016/j.vaccine.2016.04.078
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Avian influenza (AI) can represent a threat to endangered wild birds, as demonstrated with the H5N1 highly pathogenic AI (HPAI) outbreaks. Vaccination against AI using inactivated H5-vaccines has been shown to induce humoral immune response in zoo bird species. In this study, the long-term efficacy of H5-vaccination was evaluated in flamingoes from Barcelona Zoo. Specific H5-antibody titres were maintained at high levels (geometric mean titres >= 32) for over 7 years after vaccination, both against the H5N9 and H5N3 vaccine strains, as well as H5N3 and H5N1 reference strains. In addition the breadth of the immune response was also studied by testing antibody production against H1-, H3-, H4-, H7-, and H10 subtypes. It was observed that most flamingoes presented specific antibodies against H1 virus subtypes, but titres to the other HA-subtypes were rarely detected. We show that AI-vaccines can induce immunity lasting seven years in flamingoes, which suggests that vaccination can provide long term protection from HPAI outbreaks in zoo birds. (C) 2016 Published by Elsevier Ltd.
引用
收藏
页码:3082 / 3086
页数:5
相关论文
共 50 条
  • [31] AVIAN INFLUENZA H5N1 VIRUS INDUCES CYTOPATHY AND PROINFLAMMATORY CYTOKINE RESPONSES IN HUMAN ASTROCYTIC AND NEURONAL CELL LINES
    Ng, Y. P.
    Lee, S. M. Y.
    Cheung, T. K. W.
    Nicholls, J. M.
    Peiris, J. S. M.
    Ip, N. Y.
    NEUROSCIENCE, 2010, 168 (03) : 613 - 623
  • [32] Efficacy of inactivated and RNA particle vaccines against a North American Clade 2.3.4.4b H5 highly pathogenic avian influenza virus in chickens
    Spackman, Erica
    Suarez, David L.
    Lee, Chang -Won
    Pantin-Jackwood, Mary J.
    Lee, Scott A.
    Youk, Sungsu
    Ibrahim, Sherif
    VACCINE, 2023, 41 (49) : 7369 - 7376
  • [33] Intranasal vaccination with H5, H7 and H9 hemagglutinins co-localized in a virus-like particle protects ferrets from multiple avian influenza viruses
    Tretyakova, Irina
    Pearce, Melissa B.
    Florese, Ruth
    Tumpey, Terrence M.
    Pushko, Peter
    VIROLOGY, 2013, 442 (01) : 67 - 73
  • [34] Potent Vesicular Stomatitis Virus-Based Avian Influenza Vaccines Provide Long-Term Sterilizing Immunity against Heterologous Challenge
    Schwartz, Jennifer A.
    Buonocore, Linda
    Suguitan, Amorsolo L., Jr.
    Silaghi, Alex
    Kobasa, Darwyn
    Kobinger, Gary
    Feldmann, Heinz
    Subbarao, Kanta
    Rose, John K.
    JOURNAL OF VIROLOGY, 2010, 84 (09) : 4611 - 4618
  • [35] Combined H5ND inactivated vaccine protects chickens against challenge by different clades of highly pathogenic avian influenza viruses subtype H5 and virulent Newcastle disease virus
    Ali, Ahmed
    Safwat, Marwa
    Kilany, Walid H.
    Nagy, Abdou
    Shehata, Awad A.
    El-Abideen, Mohamed A. Zain
    Dahshan, Al-Hussien M.
    Arafa, Abdel-Satar A.
    VETERINARY WORLD, 2019, 12 (01) : 97 - 105
  • [36] Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination
    Gonzalez-Perez, Maria
    Montes-Casado, Maria
    Conde, Patricia
    Cervera, Isabel
    Baranda, Jana
    Berges-Buxeda, Marcos J.
    Perez-Olmeda, Mayte
    Sanchez-Tarjuelo, Rodrigo
    Utrero-Rico, Alberto
    Lozano-Ojalvo, Daniel
    Torre, Denis
    Schwarz, Megan
    Guccione, Ernesto
    Camara, Carmen
    Llopez-Carratala, M. Rosario
    Gonzalez-Parra, Emilio
    Portoles, Pilar
    Ortiz, Alberto
    Portoles, Jose
    Ochando, Jordi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [37] Rapid and broad detection of H5 hemagglutinin by an immunochromatographic kit using novel monoclonal antibody against highly pathogenic avian influenza virus belonging to the genetic clade 2.3.4.4
    Lam Thanh Nguyen
    Nakaishi, Kazunari
    Motojima, Keiko
    Ohkawara, Ayako
    Minato, Erina
    Maruyama, Junki
    Hiono, Takahiro
    Matsuno, Keita
    Okamatsu, Masatoshi
    Kimura, Takashi
    Takada, Ayato
    Kida, Hiroshi
    Sakoda, Yoshihiro
    PLOS ONE, 2017, 12 (08):
  • [38] Effect of passive immunization on immunogenicity and protective efficacy of vaccination against a Mexican low-pathogenic avian H5N2 influenza virus
    Forrest, Heather L.
    Garcia, Alejandro
    Danner, Angela
    Seiler, Jon P.
    Friedman, Kimberly
    Webster, Robert G.
    Jones, Jeremy C.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2013, 7 (06) : 1194 - 1201
  • [39] A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice
    Liyun Zheng
    Fuyan Wang
    Zhongdong Yang
    Jianjun Chen
    Haiyan Chang
    Ze Chen
    BMC Infectious Diseases, 9
  • [40] A Live Attenuated Influenza A(H5N1) Vaccine Induces Long-Term Immunity in the Absence of a Primary Antibody Response
    Talaat, Kawsar R.
    Luke, Catherine J.
    Khurana, Surender
    Manischewitz, Jody
    King, Lisa R.
    McMahon, Bridget A.
    Karron, Ruth A.
    Lewis, Kristen D. C.
    Qin, Jing
    Follmann, Dean A.
    Golding, Hana
    Neuzil, Kathleen M.
    Subbarao, Kanta
    JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (12) : 1860 - 1869